International Assets Investment Management’s Anixa Biosciences ANIX Stock Holding History

International Assets Investment Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,000	Closed	-$26.1K	–	767
2024 Q4	$26.1K	Sell	11,000 -26,800	-71%	-$83.2K	﹤0.01%	824
2024 Q3	$12K	Buy	37,800 +23,800	+170%	+$73.2K	0.03%	391
2024 Q2	$30.9K	Hold	14,000	–	–	﹤0.01%	1347
2024 Q1	$46.9K	Hold	14,000	–	–	﹤0.01%	754
2023 Q4	$54.3K	Sell	14,000 -500	-3%	-$1.69K	0.01%	698
2023 Q3	$47.1K	Hold	14,500	–	–	0.01%	591
2023 Q2	$46.4K	Hold	14,500	–	–	0.01%	589
2023 Q1	$62.4K	Buy	14,500 +3,500	+32%	+$15.3K	0.01%	653
2022 Q4	$46.8K	Buy	+11,000	New	+$52.9K	﹤0.01%	751

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

International Assets Investment Management's ANIX Position: Q1 2025 in Review

International Assets Investment Management sold out of Anixa Biosciences (ANIX) in Q1 2025, closing a stake of 11,000 shares — an estimated $26.1K sold.

International Assets Investment Management first reported a position in ANIX in Q4 2022 and held it in 9 quarters. The position peaked at $62.4K in Q1 2023. 58 funds tracked by Wall St. Rank hold ANIX as of Q1 2025.

International Assets Investment Management reported no remaining Anixa Biosciences position as of Q1 2025 after selling out during the quarter.
International Assets Investment Management sold 11,000 Anixa Biosciences shares in Q1 2025, an estimated $26.1K.
International Assets Investment Management first reported a position in Anixa Biosciences in Q4 2022 and held it in 9 quarters.
International Assets Investment Management's Anixa Biosciences position peaked at $62.4K in Q1 2023.
58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2025.

Based on International Assets Investment Management's 13F filing for Q1 2025, filed 23 Apr 2025.